Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
about
Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.MALDI-ion mobility-TOFMS imaging of lipids in rat brain tissue.Label-free calcium imaging in ischemic retinal tissue by TOF-SIMS.Cluster TOF-SIMS imaging: a new light for in situ metabolomics?An introduction to sphingolipid metabolism and analysis by new technologiesLipid mapping of colonic mucosa by cluster TOF-SIMS imaging and multivariate analysis in cftr knockout mice.Lipid imaging by mass spectrometry - a review.Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Lipid imaging with time-of-flight secondary ion mass spectrometry (ToF-SIMS).Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS).Lipid mapping in human dystrophic muscle by cluster-time-of-flight secondary ion mass spectrometry imaging.Sphingolipidomics: methods for the comprehensive analysis of sphingolipids.Lipidomics of glycosphingolipids.In situ calcium mapping in the mouse retina via time-of-flight secondary ion mass spectrometry: modulation of retinal angiogenesis by calcium ion in development and oxygen-induced retinopathy.Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease.Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients.Localization of fatty acids with selective chain length by imaging time-of-flight secondary ion mass spectrometry.
P2860
Q30422058-EACECD6A-0870-4F33-AFFF-6E0990659485Q33290371-FB8D4511-D863-4D88-811E-2F2709BD4349Q33316916-8AA8E56C-11DF-42F5-8730-0557DB29B933Q33361364-FB7FAAD3-460B-4E8B-B25E-BE81EDD73380Q33648081-322A77BF-757A-45F1-B50C-61BCC5868AD4Q34116335-69DFD5C7-D4A2-405B-B920-483021A3F4E6Q34546576-EEA4A6CA-9192-42C9-A1B2-35FDBBC1B977Q35324757-41D721D4-3710-48C5-BB98-45FE062D3C95Q35421692-D8E07A9D-E2A9-46C5-9FDE-38830E66CF33Q35490082-AE2E114F-FE9A-453C-81B5-B10F9E38EFBAQ36734827-3F1A4A30-0FB5-4C3A-80D2-4E54143766BCQ37369553-9A78C13A-43FF-4A50-B605-1FC1192CA8E6Q37512584-CF6AEE7A-402F-4EDF-8C1B-87D5815A1548Q38498409-AB4CFDEF-EB3E-4F3C-8556-8DC5F9C6C6F5Q43138779-F4C34BFA-C4B5-4FAC-AF53-BF85FE03F6BAQ46680951-E2B105C2-0134-43ED-B72F-E77E6CB276A4Q48225087-12B9DCD3-A980-4502-A204-AEF6115D132E
P2860
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@en
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@nl
type
label
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@en
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@nl
prefLabel
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@en
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@nl
P2093
P1476
Distribution of cholesterol and galactosylceramide in rat cerebellar white matter.
@en
P2093
Birgit Hagenhoff
Elke Tallarek
Håkan Nygren
Jan-Eric Månsson
Katrin Börner
P304
P356
10.1016/J.BBALIP.2006.02.021
P50
P577
2006-03-24T00:00:00Z